Unlocking Potential: How Presidential Industrial Hubs Can Transform Rwenzori Sub-Region into a Hub of Production and Innovation

Welcome to the Blog Post! Eng. Kamugisha Urges Rwenzori Sub-region Leaders to Utilize Presidential Industrial Hubs As the Director Presidential Projects and Industrial Hubs at State House, Eng. Raymond Kamugisha recently visited leaders in the Rwenzori Sub-region, he had a special message for them. During his tour, Eng. Kamugisha highlighted the importance of utilizing the…

Read More

30 Playsets in 30 Days: How One Foundation is Kicking Cancer’s Butt, One Swing Set at a Time!

Nonprofit Builds Hope for Families Across the United States Roc Solid Foundation: Play Defeats Cancer Tour Have you ever heard of a nonprofit organization that builds custom playsets for children fighting cancer? Meet Roc Solid Foundation, a beacon of hope for families across the United States who are battling pediatric cancer. Their latest initiative, the…

Read More

Say Goodbye to Screen Switching: Pepperstone Introduces Spread Betting on TradingView for a Seamless Trading Experience

Pepperstone Introduces ‘Tax-Free’ Spread Betting on TradingView Say Goodbye to “Screen Switching” Pepperstone, the Australia-based online trading provider that integrated with TradingView early last year, has now introduced ‘tax-free’ spread betting for its users on the social charting platform. According to the forex and contract for difference (CFDs) brokerage, its UK customers can now make…

Read More

Introducing BeFake: The AI-Powered Social Media App from Alias Technologies, Now Out of Stealth Mode with $3M in Seed Funding!

Welcome to the World of BeFake! The Rise of Alias Technologies SAN FRANCISCO, Aug. 31, 2023 (GLOBE NEWSWIRE) — Alias Technologies has officially emerged from stealth mode with the launch of BeFake, an innovative AI-driven social media app that is revolutionizing the way we connect with our friends and share our everyday moments. With $3M…

Read More

Breaking News: Foghorn Therapeutics Doses First Patient in Revolutionary AML Study!

Today, a groundbreaking development in the field of biotechnology has taken place. Foghorn® Therapeutics Inc., a clinical-stage biotechnology company, has announced the dosing of the first patient in the Phase 1 study of FHD-286 in combination with decitabine or cytarabine in relapsed and/or refractory acute myeloid leukemia (AML). This news marks a significant milestone in…

Read More

Revolutionizing Heart Health: HeartSciences Partners with FJ Medical Denmark for Global Distribution

HeartSciences Signs Distribution Agreement with FJ Medical, Denmark Southlake, TX, Aug. 31, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it has signed…

Read More